G R E AT E R H A R T F O R D ' S B U S I N E S S N E W S w w w. H a r t f o rd B u s i n e s s . c o m
For more B2B news visit
AUGUST 8, 2016
Volume 24, Number 36
$3.00
Subscribe
online
JOIN US!
'BLACK TIE &
BLUE JEANS'
ANNIVERSARY EVENT
WEDNESDAY, SEPT. 14, 2016
CT CONVENTION CENTER | HARTFORD
20th
ANNIVERSARY
19
9
7-2
0
1
6
Index
■ Week in Review: PG. 6
■ Focus: PG. 8
■ The List: PG. 10
■ Deal Watch: PG. 16
■ Corporate Profile: PG. 16
■ Movers & Shakers: PG. 18
■ Opinion & Commentary: PG. 20
Untaxed Burden
A new Hartford Business Journal analysis has
found that 59 percent of the real estate within the
city of Hartford is untaxed because its owners are
nonprofits or other tax-exempt entities. PG. 3
FOCUS: STARTUPS &
ENTREPRENEURS
Meeting of the Minds
As Connecticut puts more focus on attracting and
supporting startups, the state has begun to see the
emergence of startup specific networking
organizations. PG. 8
Low oil prices present
early challenge to
CT's $7B gas expansion
By Matt Pilon
mpilon@HartfordBusiness.com
W
hen Connecticut launched
its ambitious $7 billion,
10-year effort in 2014 to
convert approximately 280,000
utility customers to natural gas,
the plan's success hinged on fed-
eral government projections that
oil prices would climb for the next
decade or more.
But that hasn't happened
so far. In fact, oil prices nose-
dived in 2014 and have remained
at depressed levels, causing
the state to fall behind its pro-
jected natural gas conversion
pace early on.
Utilities say they're confident
Building
Bioscience
A N H B J S E R I E S O N C T ' S B I O S C I E N C E S E C T O R
Vaccine
Voyage
Dual CEO Almassian tees up
CaroGen's next stage
After decades in the biotech industry, Bijan
Almassian is leading the charge to raise millions of
dollars for Farmington vaccine maker CuroGen.
P
H
O
T
O
|
S
T
E
V
E
L
A
S
C
H
E
V
E
R
H
artford Business Journal's year-long
series on Connecticut's bioscience
industry continues this week with a
look at Farmington-based CaroGen and its
co-founder Bijan Almassian.
The company is developing a therapeutic
vaccine to treat various viruses including
Hepatitis B and Zika.
CaroGen is also on the cusp of raising poten-
tially millions of dollars to advance its research
to clinical trials.
Find out more on
PG. 12
Continued on page 14
A construction
crew works on a
natural gas
pipeline expansion.
P
H
O
T
O
|
C
O
N
T
R
I
B
U
T
E
D